Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study

BACKGROUND: Platinum-based chemoradiotherapy is the standard treatment for unresectable stage III non-small-cell lung cancer (NSCLC). However, few studies have evaluated the efficacy of subsequent chemotherapy for relapsed NSCLC following platinum-based chemoradiotherapy. This study aimed to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyawaki, Eriko, Kenmotsu, Hirotsugu, Shintani, Yasushi, Sekine, Ikuo, Shukuya, Takehito, Takayama, Koichi, Inoue, Akira, Okamoto, Isamu, Kiura, Katsuyuki, Takahashi, Kazuhisa, Yamamoto, Nobuyuki, Kawaguchi, Tomoya, Miyaoka, Etsuo, Yoshino, Ichiro, Date, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962203/
https://www.ncbi.nlm.nih.gov/pubmed/35351059
http://dx.doi.org/10.1186/s12885-022-09441-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962203/
https://www.ncbi.nlm.nih.gov/pubmed/35351059
http://dx.doi.org/10.1186/s12885-022-09441-3

Ejemplares similares